GON(SZ:002768)2022-08-30 16:00Financial Performance - The company's operating revenue for the first half of 2022 was ¥6,131,515,333.83, representing a 47.76% increase compared to ¥4,149,557,993.76 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥379,025,078.80, up 7.63% from ¥352,159,095.06 in the previous year[22]. - The net cash flow from operating activities increased by 36.98% to ¥311,474,410.07, compared to ¥227,385,498.76 in the same period last year[22]. - Basic earnings per share rose to ¥1.40, reflecting a 7.69% increase from ¥1.30 in the previous year[22]. - Total assets at the end of the reporting period reached ¥11,321,164,433.13, a 14.25% increase from ¥9,908,877,185.13 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company increased by 8.87% to ¥3,784,321,189.39, compared to ¥3,475,953,942.84 at the end of the previous year[22]. - The total profit reached 480 million yuan, an increase of 20.62% compared to the previous year[49]. - The company achieved a significant increase in sales in the Yangtze River Delta region, with revenue of ¥3,036,282,440.8, a 60.31% increase year-on-year[67]. - The company reported a total profit of ¥480,334,753.73 for the first half of 2022, compared to ¥398,234,049.92 in the same period of 2021, representing an increase of 20.6%[178]. Investment and Expansion - The company is actively investing in a 1 million tons/year polystyrene project and a 200,000 tons/year polypropylene resin production line to enhance its core competitiveness[31]. - The company has completed acquisitions to enhance its integrated industrial platform, extending its reach into upstream gelatin production and downstream capsule manufacturing[41]. - The company is currently engaged in significant non-equity investments, including a project for the production of hollow capsules with an investment of ¥5,896,000, which is in the construction phase[79]. - The company plans to enhance its supply chain management to mitigate the impact of raw material price fluctuations, particularly in light of rising oil prices[92]. - The company aims to increase investment in technology and R&D to continuously launch high-value-added new products, ensuring a competitive edge[93]. - The company has initiated a strategic acquisition plan to enhance its technological capabilities, with a budget allocation of 500 million RMB for potential targets[194]. Research and Development - Research and development investment rose by 29.41% to ¥161,368,011.26, up from ¥124,691,783.14, driven by increased R&D activities and personnel[64]. - The company has focused on optimizing raw material procurement and production efficiency, enhancing its operational capabilities in the health industry[59]. - The company has made technological breakthroughs in biodegradable modified materials, developing products that meet EU and US biodegradable testing standards[34]. - The company has achieved certifications for environmental management and occupational health and safety management systems, with no major safety or environmental incidents reported[108]. - Research and development expenses for the first half of 2022 amounted to 268 million RMB, accounting for 2.2% of total revenue, reflecting the company's commitment to innovation[194]. Market and Product Development - The company has developed a vertical integration industrial platform focusing on the large chemical and health industries, with a diverse product range including chemical raw materials and biodegradable materials[30]. - The company is expanding its artificial turf business, which is seeing increased demand due to the national fitness plan and the growing popularity of recreational products[36]. - The company has launched a series of upgraded retail products since 2021, including collagen peptide powder and collagen drinks, aiming to expand brand influence and market share[38]. - The company is actively involved in the research and development of new materials for the telecommunications industry, including 5G infrastructure[53]. - The company plans to expand its market presence by launching new products in the second half of 2022, aiming for a 15% increase in market share[194]. Risk Management - The company has detailed potential risks and countermeasures in the report, which can be found in the management discussion and analysis section[3]. - The company faces management risks due to the expansion of its operational scale, necessitating improvements in management capabilities[88]. - The company is exposed to exchange rate risks as it expands its overseas market presence, which could affect profitability[91]. - The company has established an Environmental Protection Management Committee and developed management systems and emergency response plans for environmental risks[105]. Shareholder and Governance - The company plans not to distribute cash dividends or issue bonus shares[4]. - The company emphasizes the protection of shareholder rights, particularly for minority shareholders, and maintains transparent communication through various channels[108]. - The commitments include not controlling or significantly influencing any other entities engaged in similar business activities, ensuring compliance with company regulations, and equal exercise of shareholder rights[113]. - The company has committed to avoiding future competition with itself and ensuring the legal rights of shareholders, with commitments made by controlling shareholders and actual controllers[113]. - The management team has agreed to accept penalties, including salary reductions, for any failure to meet public commitments[116]. Financial Position - The company's total liabilities as of the end of the first half of 2022 amounted to ¥4,275,461,572.07, up from ¥3,755,812,295.97 at the end of the first half of 2021, representing a rise of 13.8%[178]. - The total equity attributable to shareholders increased to CNY 3.78 billion from CNY 3.48 billion, which is an increase of approximately 8.6%[171]. - The total assets of the company reached 12,418 million RMB, indicating a growth of 9.6% year-over-year[194]. - The total liabilities at the end of the period were 947.3 million yuan[200]. - The total comprehensive income for the first half of 2022 was reported at 271,765,135.00 CNY, reflecting a substantial increase compared to the previous year's balance[189].